Lexeo Therapeutics to Participate in Upcoming Investor Conferences in September

Lexeo Therapeutics (LXEO) will participate in two investor conferences in September 2026, featuring webcast fireside chats with management in New York.

Rhea-AI Summary

Lexeo Therapeutics (LXEO) will participate in two investor conferences in September 2026, featuring webcast fireside chats with management in New York.

The company joins the Cantor Global Healthcare Conference 2026 on September 9, 2026 at 2:10 p.m. ET and the Baird 2026 Global Healthcare Conference on September 15, 2026 at 11:25 a.m. ET. Live webcasts and replays will be accessible via the Events & Presentations section of Lexeo’s investor website.

Market Reaction – LXEO

+3.62% $4.87 2.2x vol

15m delay

+3.62% Vs previous close

-16.0% Trough Tracked

$4.87 Last Price

$4.00 $5.10 Day Range

$399.57M Market Cap

2.2x Rel. Volume

Following this news, LXEO has gained 3.62%, reflecting a moderate positive market reaction. Argus tracked a trough of -16.0% from its starting point during tracking. Our momentum scanner has triggered 4 alerts so far, indicating moderate trading interest and price volatility. The stock is currently trading at $4.87. Trading volume is elevated at 2.2x the average, suggesting notable buying interest.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO) a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced that members of management will participate in the following investor conferences in September:

Cantor Global Healthcare Conference 2026. Fireside chat on Wednesday, September 9, 2026 at 2:10 p.m. ET in New York, NY.

Baird 2026 Global Healthcare Conference. Fireside chat on Tuesday, September 15, 2026 at 11:25 a.m. ET in New York, NY.

The events will be webcast live under the Events & Presentations tab in the Investors section of the Company’s website. A replay of the webcasts will be available on the Lexeo website following the presentations.

About Lexeo Therapeutics
Lexeo Therapeutics is a New York City-based, clinical stage genetic medicine company dedicated to reshaping heart health by applying pioneering science to fundamentally change how cardiovascular diseases are treated. The Company is advancing a portfolio of therapeutic candidates that take aim at the underlying genetic causes of conditions, including LX2006 in Friedreich ataxia (FA), LX2020 in plakophilin-2 (PKP2) arrhythmogenic cardiomyopathy, and others in devastating diseases with high unmet need.

Media Response:
Media@lexeotx.com

Investor Response:
Ashley Kaplowitz
akaplowitz@lexeotx.com

FAQ

When will Lexeo Therapeutics (LXEO) present at the Cantor Global Healthcare Conference 2026?

Lexeo Therapeutics will hold a fireside chat at the Cantor Global Healthcare Conference 2026 on in New York, NY.

What is the date and time of Lexeo Therapeutics (LXEO) presentation at the Baird 2026 Global Healthcare Conference?

Lexeo Therapeutics is scheduled for a fireside chat at the Baird 2026 Global Healthcare Conference on Tuesday, September 15, 2026 at 11:25 a.m. ET in New York, NY.

How can investors access the Lexeo Therapeutics (LXEO) September 2026 conference webcasts?

The fireside chats will be webcast live under the Events & Presentations tab in the Investors section of the Lexeo Therapeutics website. A replay of the webcasts will also be available on the company’s website following the presentations.

Will replays be available for Lexeo Therapeutics (LXEO) September 2026 investor conference presentations?

Yes. A replay of the webcasts from Lexeo Therapeutics’ fireside chats at the September 2026 investor conferences will be available on the company’s website after the presentations.